AI주식인사이트AI Stock Insight
C

엘앤케이바이오

156100KOSDAQ의료용 기기 제조업

46.8 / 100

Reference Date: 2026-07-24

Financial Score8.5 / 40
News Sentiment21.3 / 25
Momentum7.0 / 20
Disclosure10.0 / 15
AI Analysis: ROE is below the industry average, PBR raises overvaluation concerns. Declined 10.3% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Elan K Bio is a specialized medical device company focusing on the design, development, manufacturing, and sales of spinal implants used in orthopedic and neurosurgical procedures. Its products, classified as Class 3 medical devices, account for 95.9% of revenue generated primarily in the Americas.

Number of Employees

97people

Average Salary

60.4M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 20.044.0Point
PBR
2.36Industry Average 1.140.0Point

2.1x industry avg (risky)

ROE
-44.98Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
16.87Industry Average 11.652.0Point

Higher than industry avg (caution)

Trend 2023~20252.5 / 10 points
Revenue Growth Rate
2.5 / 3

Avg ▲14.3% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼12.7% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -14.3% (declining, 3yr)

Detailed News Sentiment

4 totalPositive 4Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position1.0Point

Near 52w low (1%, downtrend)

Current 4,080Won52-week high 15,89052-week low 3,960
1-month return1.0Point

1m -10.33% (falling)

Volume trend5.0Point

Volume increasing

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0
  • Neutral기업설명회(IR)개최2026-07-22
  • Neutral주식등의대량보유상황보고서(일반)2026-07-20
  • Neutral주식등의대량보유상황보고서(일반)2026-07-06